π Introducing Infinia Research - Unlocking Infinite Potential π
The official X handle of Infinia Research - a SEBI Registered Research Analyst firm dedicated to bringing independent, research-backed equity ideas to serious traders & investors.
π§΅ Everything about us π
Scrip: EIH - OBEROI HOTELS
NSE: EIHOTEL
Segment: Cash
Action: BUY ABOVE 325.00
Targets: 328.00 | 331.00 | 334.00
Stop Loss: 321.00
RRR: 0.75 | 1.50 | 2.25
Volatility: Extreme
Volume Risk: High
Validity: IntraDay (Square-off by 3:15 PM IST)
Distribution: Public Channel (Sample) + Paid Subscribers
Risk Profile: High (Intraday | Leveraged-suitable | Aggressive)
βββββββββββββββββ
β±οΈ Base TF: 5-Min | π Data As Of: 2026-11-13 09:25:00
π Rationale: 50-EMA above 200-EMA (Golden trend); Strong ADX trend (41, +DI dominant); 1H ADX strong (50); MACD momentum positive; 15m MACD momentum positive; Immediate Trigger: Marubozu (Bullish) (5m @ 2026-11-13 09:25:00).
βΉοΈ Valid ONLY at stated entry trigger. Chased entries at subscriber's own risk.
βββββββββββββββββ
βοΈ Disclosures:
β’ Holdings (RA / Relatives / Associates): NO
β’ Compensation from subject company (last 12M): NIL
β’ No material conflict of interest.
β’ Principal Officer: Kamlesh D Katarmal.
βββββββββββββββββ
INFINIA RESEARCH | SEBI: INH000026585 | BASL: 7089
βββββββββββββββββ
π FREE SAMPLE CALL | Public Channel
βββββββββββββββββ
β οΈ This is a sample recommendation shared on our public channel for awareness. Subscription to research services is optional and based solely on your own due diligence. No assurance of trade frequency, accuracy, or returns is implied.
βββββββββββββββββ
Discl: Illustrative & educational analysis; securities quoted are not recommendatory. Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Full Profile, Charter, MITC, SCORES, ODR & Disclaimers in bio.
Scrip: UNITED SPIRITS
NSE: UNITDSPR
Segment: Cash
Action: BUY ABOVE 1455.00
Targets: 1469.00 | 1483.00 | 1497.00
Stop Loss: 1440.00
RRR: 0.93 | 1.87 | 2.80
Volatility: Extreme
Validity: IntraDay (Square-off by 3:15 PM IST)
Distribution: Public Channel (Sample) + Paid Subscribers
Risk Profile: High (Intraday | Leveraged-suitable | Aggressive)
βββββββββββββββββ
β±οΈ Base TF: 5-Min | π Data As Of: 2026-11-11 09:45:00
π Rationale: 50-EMA above 200-EMA (Golden trend); Strong ADX trend (44, +DI dominant); 1H ADX strong (56); MACD momentum positive; 15m MACD momentum positive; Immediate Trigger: Marubozu (Bullish) (5m @ 2026-11-11 09:45:00).
βΉοΈ Valid ONLY at stated entry trigger. Chased entries at subscriber's own risk.
βββββββββββββββββ
βοΈ Disclosures:
β’ Holdings (RA / Relatives / Associates): NO
β’ Compensation from subject company (last 12M): NIL
β’ No material conflict of interest.
β’ Principal Officer: Kamlesh D Katarmal.
Illustrative & educational analysis; securities quoted are not recommendatory. Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Full Profile, Charter, MITC, SCORES, ODR & Disclaimers in bio.
βββββββββββββββββ
INFINIA RESEARCH | SEBI: INH000026585 | BASL: 7089
βββββββββββββββββ
π FREE SAMPLE CALL | Public Channel
βββββββββββββββββ
β οΈ This is a sample recommendation shared on our public channel for awareness. Subscription to research services is optional and based solely on your own due diligence. No assurance of trade frequency, accuracy, or returns is implied.
βββββββββββββββββ
π Strong Q2FY27 from Suraksha Diagnostics ($SURAKSHA)!
The company just delivered a massive 69% YoY jump in profits, backed by solid top-line growth and aggressive asset execution.
π The Key Numbers (Consolidated):
β’ Revenue: βΉ99.07 Cr (β¬οΈ 26% YoY)
β’ Net Profit: βΉ15.00 Cr (β¬οΈ 69% YoY)
β’ H1FY27 Profit: βΉ27.80 Cr (β¬οΈ 54% YoY)
#SurakshaDiagnostics #Q2Earnings #StockMarketIndia #HealthcareStocks #Investing
Discl: Illustrative & educational analysis; securities quoted are not recommendatory. Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Full Profile, Charter, MITC, SCORES, ODR & Disclaimers in bio.
Access Full PDF: https://t.co/LEFgkrB2nN
Discl: Illustrative & educational analysis; securities quoted are not recommendatory. Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Full Profile, Charter, MITC, SCORES, ODR & Disclaimers in bio.
πͺ Diwali Special πͺ
Sharing 1 FREE Investment Idea here on X this Diwali! π
No Intraday/Swing trade ideas for Muhurat session.
We're avoiding speculative & high-risk trades. π±
Happy Diwali! β¨
#Diwali #MuhuratTrading #Investing
π―π―π― SAILIFE...1725--->1775...All Target ACHIEVED β β Call objective met!
π‘ Conservative Traders: Book remaining position & close trade.
π Aggressive Traders: Trail SL up to T3 level and ride extended momentum β square-off mandatory by 3:15 PM IST.
Scrip: SAI LIFE SCIENCES
NSE: SAILIFE
Segment: Cash
Action: BUY ABOVE 1725.00
Targets: 1742.00 | 1759.00 | 1776.00
Stop Loss: 1707.00
RRR: 0.94 | 1.89 | 2.83
Volatility: Extreme
Validity: IntraDay (Square-off by 3:15 PM IST)
Distribution: Public Channel (Sample) + Paid Subscribers
Risk Profile: High (Intraday | Leveraged-suitable | Aggressive)
βββββββββββββββββ
β±οΈ Base TF: 5-Min | π Data As Of: 2026-11-06 09:20:00
π Rationale: 50-EMA above 200-EMA (Golden trend); Strong ADX trend (30, +DI dominant); 1H ADX strong (40); MACD momentum positive; 15m MACD momentum positive; Immediate Trigger: Marubozu (Bullish) (3m @ 2026-11-06 09:24:00).
βΉοΈ Valid ONLY at stated entry trigger. Chased entries at subscriber's own risk.
βββββββββββββββββ
βοΈ Disclosures:
β’ Holdings (RA / Relatives / Associates): NO
β’ Compensation from subject company (last 12M): NIL
β’ No material conflict of interest.
β’ Principal Officer: Kamlesh D Katarmal.
π’ Standard Warnings, Full Profile, Charter, MITC & Refund Rules, Scores, ODR: Link in Bio.
βββββββββββββββββ
INFINIA RESEARCH | SEBI: INH000026585 | BASL: 7089
βββββββββββββββββ
π FREE SAMPLE CALL | Public Channel
βββββββββββββββββ
β οΈ This is a sample recommendation shared on our public channel for awareness. Subscription to research services is optional and based solely on your own due diligence. No assurance of trade frequency, accuracy, or returns is implied.
βββββββββββββββββ
π―π―π― SAILIFE...1725--->1768...TARGET 3 ACHIEVED β β Call objective met!
π‘ Conservative Traders: Book remaining position & close trade.
π Aggressive Traders: Trail SL up to T2 level and ride extended momentum β square-off mandatory by 3:15 PM IST.
Scrip: SAI LIFE SCIENCES
NSE: SAILIFE
Segment: Cash
Action: BUY ABOVE 1725.00
Targets: 1742.00 | 1759.00 | 1776.00
Stop Loss: 1707.00
RRR: 0.94 | 1.89 | 2.83
Volatility: Extreme
Validity: IntraDay (Square-off by 3:15 PM IST)
Distribution: Public Channel (Sample) + Paid Subscribers
Risk Profile: High (Intraday | Leveraged-suitable | Aggressive)
βββββββββββββββββ
β±οΈ Base TF: 5-Min | π Data As Of: 2026-11-06 09:20:00
π Rationale: 50-EMA above 200-EMA (Golden trend); Strong ADX trend (30, +DI dominant); 1H ADX strong (40); MACD momentum positive; 15m MACD momentum positive; Immediate Trigger: Marubozu (Bullish) (3m @ 2026-11-06 09:24:00).
βΉοΈ Valid ONLY at stated entry trigger. Chased entries at subscriber's own risk.
βββββββββββββββββ
βοΈ Disclosures:
β’ Holdings (RA / Relatives / Associates): NO
β’ Compensation from subject company (last 12M): NIL
β’ No material conflict of interest.
β’ Principal Officer: Kamlesh D Katarmal.
π’ Standard Warnings, Full Profile, Charter, MITC & Refund Rules, Scores, ODR: Link in Bio.
βββββββββββββββββ
INFINIA RESEARCH | SEBI: INH000026585 | BASL: 7089
βββββββββββββββββ
π FREE SAMPLE CALL | Public Channel
βββββββββββββββββ
β οΈ This is a sample recommendation shared on our public channel for awareness. Subscription to research services is optional and based solely on your own due diligence. No assurance of trade frequency, accuracy, or returns is implied.
βββββββββββββββββ
π― SAILIFE..1725--->1750...TARGET 1 ACHIEVED β
Book partial profits (30-50%).
Trail SL up to Entry β trade now risk-free. Hold balance for T2 & T3.
GE Vernova T&D India now has a Power Grid Letter of Award for one of the larger transmission packages in the current cycle: a 6,000 MW, Β±800 kV HVDC LCC terminal station (2x3,000 MW) to carry renewable power from Barmer II in Rajasthan to South Kalamb in Maharashtra.
Why it stands out:
- Β±800 kV is the top voltage class used in India's HVDC buildout, and very few vendors can deliver LCC terminal stations at this scale.
- The project links desert solar and wind capacity to load centres in western India, where AC transmission alone struggles.
- The award moves the company deeper into HVDC work, beyond its core substation and AC equipment business.
Disc: Illustrative GVT&D analysis for educational purposes; not a recommendation. Holding: No. Market risks & SEBI RA discl. in bio.
π― VRLLOG..345--->348...TARGET 1 ACHIEVED β
Book partial profits (30-50%).
Trail SL up to Entry β trade now risk-free.
Hold balance for T2 & T3.
SJS Q2 FY27: revenue +16.9%, PAT +34.8%, est. EBITDA margin 31.7%.
Ex the βΉ27.95 cr Q1 land gain, H1 PAT growth is ~34%, not 70%. PAT growing 2x revenue β mix shift or cost leverage?
Disc: Illustrative $SJS analysis for educational purposes; not a recommendation. Holding: No. Market risks & SEBI RA discl. in bio.
SJS Enterprises Q2 FY27 Result (consolidated)
P&L
Revenue βΉ282.73 cr, +16.9% YoY (Q2 FY26: βΉ241.76 cr)
Est. EBITDA βΉ89.67 cr -> 31.7% margin
PAT βΉ58.31 cr, +34.8% YoY -> PAT margin ~20.6% vs ~17.9% last year
H1 FY27
Revenue βΉ543.73 cr, +20.4% YoY
Reported PAT βΉ132.75 cr, +70.4% YoY
Exceptional: βΉ27.95 cr gain on sale of freehold land & building (Q1)
Adjusted PAT ~βΉ104.8 cr -> roughly +34β35% underlying
Balance sheet (Sep-26)
Total assets βΉ1,255.16 cr vs βΉ1,112.13 cr in Mar-26
Equity βΉ995.44 cr; short-term borrowings βΉ10.83 cr
H1 operating cash flow βΉ107.28 cr vs investing outflow βΉ94.78 cr
Capital allocation this half
Walter Pack: remaining 9.9% bought for βΉ19.92 cr -> 100% subsidiary (Aug-26). Implies ~βΉ200 cr valuation for the whole entity
SJS Display Electronics incorporated; βΉ5 cr infused of a βΉ50 cr approved limit
What I'd track next quarter: whether the Q2 PAT margin holds without exceptional support, and how quickly the remaining βΉ45 cr for Display Electronics gets deployed.
Disclosure: Illustrative & educational analysis on SJS Enterprises; securities quoted are not recommendatory. Financial interest / 1%+ holding: No. Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Full Profile, Charter, MITC, SCORES, ODR & Disclaimers in bio.
SJS Enterprises Q2 FY27 Result (consolidated)
P&L
Revenue βΉ282.73 cr, +16.9% YoY (Q2 FY26: βΉ241.76 cr)
Est. EBITDA βΉ89.67 cr -> 31.7% margin
PAT βΉ58.31 cr, +34.8% YoY -> PAT margin ~20.6% vs ~17.9% last year
H1 FY27
Revenue βΉ543.73 cr, +20.4% YoY
Reported PAT βΉ132.75 cr, +70.4% YoY
Exceptional: βΉ27.95 cr gain on sale of freehold land & building (Q1)
Adjusted PAT ~βΉ104.8 cr -> roughly +34β35% underlying
Balance sheet (Sep-26)
Total assets βΉ1,255.16 cr vs βΉ1,112.13 cr in Mar-26
Equity βΉ995.44 cr; short-term borrowings βΉ10.83 cr
H1 operating cash flow βΉ107.28 cr vs investing outflow βΉ94.78 cr
Capital allocation this half
Walter Pack: remaining 9.9% bought for βΉ19.92 cr -> 100% subsidiary (Aug-26). Implies ~βΉ200 cr valuation for the whole entity
SJS Display Electronics incorporated; βΉ5 cr infused of a βΉ50 cr approved limit
What I'd track next quarter: whether the Q2 PAT margin holds without exceptional support, and how quickly the remaining βΉ45 cr for Display Electronics gets deployed.
Disclosure: Illustrative & educational analysis on SJS Enterprises; securities quoted are not recommendatory. Financial interest / 1%+ holding: No. Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Full Profile, Charter, MITC, SCORES, ODR & Disclaimers in bio.
Scrip: GREENPLY INDUSTRIES
NSE: GREENPLY
Segment: Cash
Action: BUY ABOVE 266.00
Targets: 268.00 | 270.00 | 272.00
Stop Loss: 263.00
RRR: 0.67 | 1.33 | 2.00
Volatility: Extreme
Volume Risk: High
Validity: IntraDay (Square-off by 3:15 PM IST)
Distribution: Public Channel (Sample) + Paid Subscribers
Risk Profile: High (Intraday | Leveraged-suitable | Aggressive)
βββββββββββββββββ
β±οΈ Base TF: 5-Min | π Data As Of: 2026-11-04 09:25:00
π Rationale: Strong ADX trend (47, +DI dominant); 1H ADX strong (30); MACD momentum positive; 15m MACD momentum positive; 9-MA above 21-MA; Immediate Trigger: Engulfing (Bullish) (3m @ 2026-11-04 09:27:00).
βΉοΈ Valid ONLY at stated entry trigger. Chased entries at subscriber's own risk.
βββββββββββββββββ
βοΈ Disclosures:
β’ Holdings (RA / Relatives / Associates): NO
β’ Compensation from subject company (last 12M): NIL
β’ No material conflict of interest.
β’ Principal Officer: Kamlesh D Katarmal.
β οΈ Standard Warnings: Click Here
π’ Full Profile, Charter, MITC & Refund Rules, Scores, ODR: Click Here
βββββββββββββββββ
INFINIA RESEARCH | SEBI: INH000026585 | BASL: 7089
βββββββββββββββββ
π FREE SAMPLE CALL | Public Channel
βββββββββββββββββ
β οΈ This is a sample recommendation shared on our public channel for awareness. Subscription to research services is optional and based solely on your own due diligence. No assurance of trade frequency, accuracy, or returns is implied.
βββββββββββββββββ
GE Vernova T&D India has received a Letter of Award dated Nov 3, 2026 from Power Grid for the 6000 MW, Β±800 kV HVDC LCC terminal station (2x3000 MW) β Barmer II to South Kalamb RE evacuation. Follows L1 intimation on Sept 7.
Definitive agreement to be executed in due course. Contract value not disclosed.
Disc: Summary of GVT&D exchange filing for educational purposes; not a recommendation. Holding: No. Market risks & SEBI RA discl. in bio.